Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-07-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stress and Anxiety Effects on Overactive Bladder

NCT05087810

Overactive Bladder Stress, Psychological Anxiety

TERMINATED

Interventions to Decrease Anxiety in Patients Undergoing Urodynamic Testing

NCT02168556

Incontinence

COMPLETED NA

Urodynamic Testing: Can we Improve Patient Experience?

NCT02742389

Urinary Incontinence Urinary Bladder, Overactive Lower Urinary Tract Symptoms

COMPLETED NA

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

NCT01540786

Healthy Subjects Overactive Bladder

TERMINATED PHASE1

Environmental Factors to Increase Patient Comfort During Urodynamics Testing

NCT03317340

Lower Urinary Tract Symptoms Urologic Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The results of urodynamic tests often determine treatment for patients, which may include bladder retraining, medication and/or surgery. Thus, it is important for the results of urodynamics to be accurate and representative of the patient's symptoms outside of the clinic.

Pre-test anxiety levels in women undergoing urodynamics will be measured using a validated questionnaire HADS (Hospital anxiety and depression scale). The patient, prior to their routine urodynamics test, will fill out this self-administered questionnaire.

Reproducibility of patient symptoms will be measured using a non-validated quantitative bladder test assessment. The patient will fill out this self-administered quantitative bladder assessment after their urodynamics test.

The pre-test anxiety and symptom reproducibility variables will be correlated against each other to assess whether there is correlation between the two. A Spearman Rho test will be used to assess the strength of the relationship.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Overactive Bladder Urinary Incontinence, Stress Urinary Incontinence, Urge Urinary Retention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women attending for their first time to the urodynamics clinic for the assessment of their bladder function
* Must be over the age of 18 years old
* Must be able to consent for themselves

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No